D. Labie and J. Elion, Modulation polyg??nique des maladies monog??niques : l'exemple de la dr??panocytose, m??decine/sciences, vol.12, issue.3, pp.341-390, 1996.
DOI : 10.4267/10608/737

M. Steinberg, 6 Pathophysiology of sickle cell disease, Bailli??re's Clinical Haematology, vol.11, issue.1, pp.163-184, 1998.
DOI : 10.1016/S0950-3536(98)80074-7

A. Driss, K. Asare, and J. Hibbert, Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype, Genomics Insights, vol.2009, pp.23-48, 2009.

E. Van-coillie, J. Van-damme, and G. Opdenakker, The MCP/eotaxin subfamily of CC chemokines, Cytokine & Growth Factor Reviews, vol.10, issue.1, pp.61-86, 1999.
DOI : 10.1016/S1359-6101(99)00005-2

A. Rivera, P. Jarolim, and C. Brugnara, Modulation of Gardos channel activity by cytokines in sickle erythrocytes, Blood, vol.99, issue.1, pp.357-363, 2002.
DOI : 10.1182/blood.V99.1.357

M. C. Durpès, D. Nebor, and P. Mesnil, Effect of interleukin-8 and RANTES on the Gardos channel activity in sickle human red blood cells: Role of the Duffy antigen receptor for chemokines, Blood Cells, Molecules, and Diseases, vol.44, issue.4, pp.219-223, 2010.
DOI : 10.1016/j.bcmd.2010.02.001

P. An, G. Nelson, and L. Wang, Modulating influence on HIV/AIDS by interacting RANTES gene variants, Proceedings of the National Academy of Sciences, vol.99, issue.15, pp.10002-10007, 2010.
DOI : 10.1073/pnas.142313799

O. Dossou-yovo, I. Zaccaria, and M. Benkerrou, variant with protection against infections, American Journal of Hematology, vol.164, issue.6, pp.378-380, 2009.
DOI : 10.1002/ajh.21411

H. Liu, D. Chao, and E. Nakayama, Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression, Proceedings of the National Academy of Sciences, vol.96, issue.8, pp.4581-4585, 1999.
DOI : 10.1073/pnas.96.8.4581

R. Nickel, V. Casolaro, and U. Wahn, Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES, The Journal of Immunology, vol.164, issue.3, pp.1612-1616, 2000.
DOI : 10.4049/jimmunol.164.3.1612

D. Mcdermott, M. Beecroft, and C. Kleeberger, Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS, vol.14, issue.17, pp.2671-2678, 2000.
DOI : 10.1097/00002030-200012010-00006

S. Chu, C. Tam, and H. Wong, Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese, Genes and Immunity, vol.158, issue.6, pp.475-479, 2007.
DOI : 10.1038/sj.gene.6364412

~. Sánchez-castan, M. Baquero, I. Sánchez-velasco, and P. , Polymorphisms in promoter are associated with pulmonary tuberculosis in CCL5 northern Spain, Int J Tuberc Lung Dis, vol.13, pp.480-485, 2009.

K. Tanaka, M. Roberts, and N. Yamamoto, Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis, International Journal of Immunogenetics, vol.114, issue.6
DOI : 10.1067/mai.2003.1506

J. Lachheb, H. Chelbi, and K. Hamzaoui, Association between RANTES polymorphisms and asthma severity among Tunisian children, Human Immunology, vol.68, issue.8, pp.675-680, 2007.
DOI : 10.1016/j.humimm.2007.04.004

M. Romana, L. Keclard, and A. Froger, Haplotypes in the Population of Guadeloupe, Hemoglobin, vol.64, issue.2, pp.77-87, 2000.
DOI : 10.3109/03630260009003426

P. Sebastiani, M. Ramoni, and V. Nolan, Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia, Nature Genetics, vol.9, issue.4, pp.435-440, 2005.
DOI : 10.1093/nar/28.8.e31

C. Hoppe, W. Kiltz, and S. Cheng, Gene interactions and stroke risk in children with sickle cell anemia, Blood, vol.103, issue.6, pp.2391-2396, 2004.
DOI : 10.1182/blood-2003-09-3015